The field of asthma therapeutics continues to expand, with promising new treatment options available that may address some of the existing barriers to successful asthma management. These approaches simplify treatment, use combinations of agents in one delivery device that have complementary actions, or ...
doi:10.1080/10245330512331389700PavlovskySantiagoTaylor & FrancisHematologyPavlovsky S. Treatment options in early stages of Hodgkin's Lym- phoma, high cure rate with lower short and long-term toxicity. Hematology 2005;10:3-5.
Long-Term Health-Related Quality of Life after Four Common Surgical Treatment Options for Breast Cancer and the Effect of Complications: A Retrospective Patient-Reported Survey among 1871 PatientsBackground: Differences in quality-of-life outcomes after different surgical breast cancer treatment op...
reatment Options]]>Tangalos E, Doody R, Tariot P.doi:10.1016/S1525-8610(01)80006-2Tangalos, EricDoody, RachelleTariot, PierreElsevier Inc.Journal of the American Medical Directors Association
CONCLUSIONS: Long-term outcome of AKI consists of a high additional mortality unrelated to treatment modality offered during hospitalization, varying evolution of renal recovery, and many comorbidities, but a mental health at the same level as the general population. 展开 ...
The long-term effects of SARS-CoV-2-associated myocarditis are not known, however, based on the experience with other viral myocarditis, it is anticipated that those with a moderate to severe decrease in left ventricular ejection fraction, almost half would recover in the next 6–12 months, 25...
develop new medications in treating all aspects of the opioid addiction cycle. Medications such asmethadone, buprenorphine, naltrexone, and lofexidine are all currently approved by the FDA to treat OUD; however, the NIH believes more "flexible treatment options" are needed to achieve long-term ...
My colleagues and I have set up theHEAL-COVIDstudy, which has recruited more than 1,000 people who have been hospitalized with COVID-19. We're aiming to identify possible treatments that could improve longer-term outcomes for these patients, and ideally prevent the onset of chronic health pr...
(EGFR)-directed agents has significantly improved the survival time of patients with metastatic CRC (mCRC), patients with metastatic disease still face a very poor 5-year survival rate less than 10%.2 ,3 The human EGFR 2 (HER2) has proven as an effective drug target in breast and gastric...
interventions and resources targeting the long-term care population, with a focus on older adults living in nursing homes or residential care facilities, has significantly improved [32,33,34]. However, there remains a noticeable lack of attention given to these topics in long-term care settings ...